Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer

Lung Cancer

Volumn 74, Issue 3, 2011, Pages 446-450

  Shumway, D ^a   Corbin, K ^b   Salgia, R ^b   Hoffman, P ^b   Villaflor, V ^b   Malik, R M ^b   Haraf, D J ^b   Vigneswaren, W T ^b   Shaikh, A Y ^c   Connell, P P ^b   Ferguson, M K ^b   Salama, J K ^d  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Image guided radiotherapy; Induction therapy; Neoadjuvant chemoradiotherapy; Non small cell lung cancer; Pneumonectomy

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; IRINOTECAN; NAVELBINE; PACLITAXEL; PEMETREXED;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE INTERVAL; DRUG EFFICACY; ESOPHAGITIS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HISTOPATHOLOGY; HUMAN; IMAGE GUIDED RADIOTHERAPY; LUNG ADENOCARCINOMA; LUNG EMBOLISM; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; NEUTROPENIA; OVERALL SURVIVAL; PATIENT POSITIONING; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RADIATION STERILIZATION; RESPIRATORY FAILURE; RESPIRATORY GATED IMAGING; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT RESPONSE; WEDGE RESECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; DISEASE PROGRESSION; FEMALE; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; RADIOTHERAPY, IMAGE-GUIDED; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 80755189955     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.05.003     Document Type: Article

References (32)

1. Douillard J.Y., Rosell R., De Lena M., Carpagnano F., Ramlau R., Gonzáles-Larriba J.L., et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006, 7:719-727.
2. Pignon J.P., Tribodet H., Scagliotti G.V., Douillard J.Y., Shepherd F.A., Stephens R.J., et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008, 26:3552-3559.
3. Roth J.A., Atkinson E.N., Fossella F., Komaki R., Bernadette Ryan M., Putnam J.B., et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 1998, 21:1-6.
4. Bogart J.A., Aronowitz J.N. Localized non-small cell lung cancer: adjuvant radiotherapy in the era of effective systemic therapy. Clin Cancer Res 2005, 11:5004s-5010s.
5. Albain K.S., Rusch V.W., Crowley J.J., Rice T.W., Turrisi A.T 3rd., Weick J.K., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995, 13:1880-1892.
6. Rusch V.W., Giroux D.J., Kraut M.J., Crowley J., Hazuka M., Johnson D., et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg 2001, 121:472-483.
7. Albain K.S., Swann R.S., Rusch V.W., Turrisi A.T 3rd., Shepherd F.A., Smith C., et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009, 374:379-386.
8. Shaikh A.Y., Haraf D.J., Salama J.K., Salgia R., Hoffman P.C., Ferguson M.K., et al. Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers. Am J Clin Oncol 2007, 30:258-263.
9. Cerfolio R.J., Bryant A.S., Spencer S.A., Bartolucci A.A. Pulmonary resection after high-dose and low-dose chest irradiation. Ann Thorac Surg 2005, 80:1224-1230. [Discussion 1230].
10. Cerfolio R.J., Bryant A.S., Jones V.L., Cerfolio R.M. Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival. Eur J Cardiothorac Surg 2009, 35:718-723. [Discussion 723].
11. Sonett J.R., Krasna M.J., Suntharalingam M., Schuetz J., Doyle L.A., Lilenbaum R., et al. Safe pulmonary resection after chemotherapy and high-dose thoracic radiation. Ann Thorac Surg 1999, 68:316-320.
12. Sonett J.R., Suntharalingam M., Edelman M.J., Patel A.B., Gamliel Z., Doyle A., et al. Pulmonary resection after curative intent radiotherapy (>59Gy) and concurrent chemotherapy in non-small-cell lung cancer. Ann Thorac Surg 2004, 78:1200-1205. [Discussion 1206].
13. Vora S.A., Daly B.D., Blaszkowsky L., McGrath J.J., Bankoff M., Supran S., et al. High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma. Cancer 2000, 89:1946-1952.
14. Suntharalingam M., Paulus R., Edelman M.J., Krasna M., Burrows W., Gore E., et al. RTOG 0229: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and high-dose radiotherapy (XRT) followed by resection and consolidative therapy for LA-NSCLC. J Clin Oncol 2010, 28:15s.
15. Fowler W.C., Langer C.J., Curran W.J., Keller S.M. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 1993, 55:986-989.
16. Deutsch M., Crawford J., Leopold K., Wolfe W., Foster W., Herndon J., et al. Phase II. study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer. Cancer 1994, 74:1243-1252.
17. Faber L.P., Kittle C.F., Warren W.H., Bonomi P.D., Taylor S.G 4th., Reddy S., et al. Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann Thorac Surg 1989, 47:669-675. [Discussion 676-7].
18. Betticher D.C., Hsu Schmitz S.F., Totsch M., Hansen E., Joss C., von Briel C., et al. Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study. Br J Cancer 2006, 94:1099-1106.
19. Voltolini L., Luzzi L., Ghiribelli C., Paladini P., Di Bisceglie M., Gotti G. Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy. Eur J Cardiothorac Surg 2001, 20:1106-1112.
20. Bueno R., Richards W.G., Swanson S.J., Jaklitsch M.T., Lukanich J.M., Mentzer S.J., et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 2000, 70:1826-1831.
21. Liu H.H., Koch N., Starkschall G., Jacobson M., Forster K., Liao Z., et al. Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: part II-margin reduction of internal target volume. Int J Radiat Oncol Biol Phys 2004, 60:1473-1483.
22. Liu H.H., Balter P., Tutt T., Choi B., Zhang J., Wang C., et al. Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 2007, 68:531-540.
23. Koch N., Liu H.H., Starkschall G., Jacobson M., Forster K., Liao Z., et al. Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: part I-correlating internal lung motion with skin fiducial motion. Int J Radiat Oncol Biol Phys 2004, 60:1459-1472.
24. Nelson C., Balter P., Morice R.C., Bucci K., Dong L., Tucker S., et al. Evaluation of tumor position and PTV margins using image guidance and respiratory gating. Int J Radiat Oncol Biol Phys 2010, 76:1578-1585.
25. Korreman S.S., Juhler-Nottrup T., Boyer A.L. Respiratory gated beam delivery cannot facilitate margin reduction, unless combined with respiratory correlated image guidance. Radiother Oncol 2008, 86:61-68.
26. Vlachaki M., Castellon I., Leite C., Perkins T., Ahmad S. Impact of respiratory gating using 4-dimensional computed tomography on the dosimetry of tumor and normal tissues in patients with thoracic malignancies. Am J Clin Oncol 2009, 32:262-268.
27. Juhler-Nøttrup T., Korreman S.S., Pedersen A.N., Persson G.F., Aarup L.R., Nyström H., et al. Interfractional changes in tumour volume and position during entire radiotherapy courses for lung cancer with respiratory gating and image guidance. Acta Oncol 2008, 47:1406-1413.
28. Britton K.R., Starkschall G., Tucker S.L., Pan T., Nelson C., Chang J.Y., et al. Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 2007, 68:1036-1046.
29. Refai M., Brunelli A., Rocco G., Ferguson M.K., Fortiparri S.N., Salati M., et al. Does induction treatment increase the risk of morbidity and mortality after pneumonectomy? A multicentre case-matched analysis. Eur J Cardiothorac Surg 2010, 37:535-539.
30. Gaissert H.A., Keum D.Y., Wright C.D., Ancukiewicz M., Monroe E., Donahue D.M., et al. POINT: operative risk of pneumonectomy-influence of preoperative induction therapy. J Thorac Cardiovasc Surg 2009, 138:289-294.
31. Krasna M.J., Gamliel Z., Burrows W.M., Sonett J.R., Kwong K.F., Edelman M.J., et al. Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation. Ann Thorac Surg 2010, 89:200-206. [Discussion 206].
32. Boffa D.J., Allen M.S., Grab J.D., Gaissert H.A., Harpole D.H., Wright C.D., et al. Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg 2008, 135:247-254.